Sign in with Google. Opens in new tab
ENTITY
Genscript Biotech

Genscript Biotech (1548 HK)

81
Analysis
Health CareHong Kong
Genscript Biotech Corp is biotech service company. The Company provides life science services and products and pre-clinical drug development services.
more
16 Nov 2024 23:00

Last Week in Event SPACE: Seven & I, PA Gooddoctor, Nec Networks, Genscript/Legend, ASM PT, Hanwha

It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...

Logo
644 Views
Share
bullishSands China
13 Nov 2024 07:57

Technically Speaking, Breakouts and Breakdowns: HONG KONG (NOVEMBER 13)

Mainland China's A-share market advanced after Trump's election as South Connect buying hit a 3 year high.  Sands China had a breakout as Macau...

Logo
303 Views
Share
13 Nov 2024 00:55

Legend Biotech (LEGN.US) Offer Update - Will Deconsolidation Increase the Chances of a Merger ?

The deconsolidation of Legend Bio may not necessarily be directly related to a potential merger, but divisions among major shareholders/co-founders...

Logo
446 Views
Share
07 Nov 2024 01:02

What Does a Trump Presidency Mean for China Healthcare?

Trump successfully elected as the US President. His reform in healthcare is to achieve the independence of US pharmaceutical supply chain and...

Logo
508 Views
Share
26 Oct 2024 23:30

APAC Healthcare Weekly (Oct 27)- Samsung Biologics, Celltrion, Astellas, Otsuka, Legend, and Zai Lab

Samsung Biologics secures largest ever contract, Celltrion announced KRW100B buyback, Astellas Pharma got label expansion approval for Vyloy,...

Logo
595 Views
Share
x